KRISTIN PASS: Open Payments
NPI 1750796561 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,981 in 87 payments from 23 companies in 2025. Trend: 2023 $1,451 · 2024 $1,746 · 2025 $1,981
Food & beverage: $1,881Education: $100
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 9 | $267 |
| PFIZER INC. | 13 | $256 |
| Novo Nordisk Inc | 9 | $156 |
| SANOFI-AVENTIS U.S. LLC | 6 | $152 |
| Lilly USA, LLC | 7 | $151 |
| Astellas Pharma US Inc | 2 | $121 |
| Inspire Medical Systems, Inc. | 2 | $103 |
| Axsome Therapeutics, Inc. | 4 | $101 |
| AstraZeneca Pharmaceuticals LP | 5 | $94 |
| ABBVIE INC. | 5 | $78 |
Products named: TZIELD, NURTEC ODT, MOUNJARO, INSPIRE, Auvelity, ELIQUIS, XIFAXAN, Rybelsus.
Industry payments across GA — which companies pay providers there.
